Product Name: Human VEGFR1 / FLT1 Antibody (Abbott patent anti-Flt1, Research Use)
Catalog Number: NBR-0498
Target Name: VEGFR1 / FLT1
Trade Name: Abbott patent anti-Flt1
Antibody Drug Description: The drug is a recombinant fully human anti-Flt1 monoclonal antibody, being developed by Abbott. Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS：N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG

  Gene Name: VEGFR1
Synonyms: FLT
Target Description: Tyrosine-protein kinase that acts as a cell-surface receptor for VEGFA, VEGFB and PGF, and plays an essential role in the development of embryonic vasculature, the regulation of angiogenesis, cell survival, cell migration, macrophage function, chemotaxis, and cancer cell invasion.
Ensembl: ENSG00000102755 
Uniprot:  P17948